| Radiomics: the bridge between medical imaging and personalized medicine P Lambin, RTH Leijenaar, TM Deist, J Peerlings, EEC de Jong, ... Nature Reviews Clinical Oncology 14 (12), 749, 2017 | 3846 | 2017 |
| Influence of gray level discretization on radiomic feature stability for different CT scanners, tube currents and slice thicknesses: a comprehensive phantom study RTHM Larue, JE van Timmeren, EEC de Jong, G Feliciani, RTH Leijenaar, ... Acta Oncologica 56 (11), 1544-1553, 2017 | 232 | 2017 |
| Tracking tumor biology with radiomics: A systematic review utilizing a radiomics quality score S Sanduleanu, HC Woodruff, EEC de Jong, JE van Timmeren, A Jochems, ... Radiotherapy and Oncology, 2018 | 226 | 2018 |
| Decision support systems for personalized and participative radiation oncology P Lambin, J Zindler, BGL Vanneste, L Van De Voorde, D Eekers, ... Advanced drug delivery reviews 109, 131-153, 2017 | 148 | 2017 |
| Radiomics applied to lung cancer: a review M Scrivener, EEC de Jong, JE van Timmeren, T Pieters, B Ghaye, X Geets Translational Cancer Research 5 (4), 398-409, 2016 | 108 | 2016 |
| Modern clinical research: How rapid learning health care and cohort multiple randomised clinical trials complement traditional evidence based medicine P Lambin, J Zindler, B Vanneste, L Van De Voorde, M Jacobs, D Eekers, ... Acta Oncologica 54 (9), 1289-1300, 2015 | 73 | 2015 |
| A comparison of the relative biological effectiveness of low energy electronic brachytherapy sources in breast tissue: a Monte Carlo study SA White, B Reniers, EEC De Jong, T Rusch, F Verhaegen Physics in Medicine & Biology 61 (1), 383, 2015 | 25 | 2015 |
| [18F] FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches EEC de Jong, W van Elmpt, RTH Leijenaar, OS Hoekstra, HJM Groen, ... European journal of nuclear medicine and molecular imaging 44 (1), 8-16, 2017 | 24 | 2017 |
| Quality assessment of positron emission tomography scans: recommendations for future multicentre trials EEC de Jong, W van Elmpt, OS Hoekstra, HJM Groen, EF Smit, ... Acta Oncologica 56 (11), 1459-1464, 2017 | 13 | 2017 |
| OC-0609: Radiomic CT features for evaluation of EGFR and KRAS mutation status in patients with advanced NSCLC EEC De Jong, W Van Elmpt, LEL Hendriks, RTH Leijenaar, ... Radiotherapy and Oncology 119, S290-S291, 2016 | 6 | 2016 |
| P2. 01-048 Early Changes in Body Composition in Metastatic Non-Small Cell Lung Cancer (NSCLC) Are Predictive for Poor Overall Survival J Degens, K Sanders, E De Jong, A Schols, A Dingemans Journal of Thoracic Oncology 12 (11), S2087-S2088, 2017 | 2 | 2017 |
| non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches EEC de Jong, W van Elmpt, RTH Leijenaar, OS Hoekstra, HJM Groen, ... Eur J Nucl Med Mol Imaging 44, 8-16, 2017 | | 2017 |
| Prospective Validation of a Prognostic Computed Tomography–Based Radiomic Signature in Stage IV Non-Small Cell Lung Cancer E de Jong, W van Elmpt, RTH Leijenaar, S Carvalho, EGC Troost, ... International Journal of Radiation Oncology• Biology• Physics 96 (2), S192, 2016 | | 2016 |
| 158P: PET/CT based imaging biomarkers for response prediction of stage IV NSCLC treated with paclitaxel–carboplatin–bevacizumab with or without nitroglycerin EEC de Jong, W Van Elmpt, RTH Leijenaar, H Groen, E Smit, R Boellaard, ... Journal of Thoracic Oncology 11 (4), S126-S127, 2016 | | 2016 |
| FDG-PET/CT Based Response Prediction of Stage IV NSCLC Treated with Paclitaxel-Carboplatin-Bevacizumab with or without Nitroglycerin EEC De Jong, W Van Elmpt, OS Hoekstra, HJM Groen, E Smit, ... JOURNAL OF THORACIC ONCOLOGY 10 (9), S654-S655, 2015 | | 2015 |
